OBM Integrative and Complementary Medicine is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. It covers all evidence-based scientific studies on integrative, alternative and complementary approaches to improving health and wellness.
Topics contain but are not limited to:
It publishes a variety of article types: original research, review, communication, opinion, case report, study protocol, comment, conference report, technical note, book review, etc.
There is no restriction on paper length, provided that the text is concise and comprehensive. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 6.1 days from acceptance to publication (median values for papers published in this journal in the first half of 2020, 1-2 days of FREE language polishing time is also included in this period). A first decision provided to authors of manuscripts submitted to this journal are approximately 3.5 weeks (median values) after submission.
Nutraceuticals and Dietary Supplements to Improve Cardiometabolic Health
Submission Deadline: September 30, 2022 (Open) Submit Now
Keith R. Martin, PhD, Assistant Professor
Center for Nutraceutical & Dietary Supplement Research, College of Health Sciences, University of Memphis, Memphis, TN 38152, USA.
Research interests: nutraceuticals; dietary supplements; chronic disease risk.
About the topic:
The purpose of this Special Issue entitled “Nutraceuticals and Dietary Supplements to Improve Cardio-metabolic Health” is to publish a rigorous, impactful volume on how dietary supplementation beneficially influences diverse cardiometabolic risk factors, i.e., metabolic syndrome (MetS), associated with chronic disease. MetS is a cluster of concomitant conditions increasing the risk of heart disease including hypertension, hyperglycemia, abdominal adiposity, and dyslipidemia. Cumulative evidence supports a role for dietary supplements and nutraceuticals in modulating myriad cardiometabolic risk factors including impaired glycemia, insulin resistance, dyslipidemias, and hypertension. The goal of this Special Issue is to provide rigorous evidence from peer-reviewed, empirical studies that supports the association between dietary supplementation of nutritive and/or non-nutritive bioactive factors, viz., nutraceuticals and mitigation of cardiometabolic risk factors. Articles using basic science approaches, animal studies, clinical/translational studies, epidemiological studies, meta-analyses, and behavioral studies are acceptable. Focus areas include the effects of phytochemicals, bioactive compounds, nutraceuticals, macro- and/or micronutrients as supplements singly or as mixtures on vascular biology and/or physiology, endothelial function, inflammation, oxidative stress, dysglycemia, insulin sensitivity, lipid and energy metabolism, blood pressure and cardiac function. Both original and review articles are acceptable with a focus on dietary supplementation and cardiometabolic health from empirical, clinical, and community-based studies.
Cardiometabolic Health; Metabolic Syndrome; Dietary Supplements; Nutraceuticals; Bioactive Agents
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.